C

클래시스

214150KOSDAQ의료용 기기 제조업

51.8 / 100

Reference Date: 2026-06-10

Financial Score20.5 / 40
News Sentiment18.3 / 25
Momentum3.0 / 20
Disclosure10.0 / 15
AI Analysis: ROE significantly exceeds the industry average but PBR raises overvaluation concerns. Plunged 17.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Classys operates three main brands (CLASSYS, Cluederm, and ShringkRX/Skedum), focusing on aesthetic medical devices, consumables, and cosmetics. The company merged with IruDa in October 2024, enhancing its technological competitiveness in key EBD segments like micro-needle RF and laser. It generates revenue from over 80 countries, with medical devices and consumables accounting for 46% and 45% of sales, respectively.

Number of Employees

528people

Average Salary

65.1M KRW

Score Calculation Basis

Detailed Financial Score

PER
22.06Industry Average 21.513.0Point

Higher than industry avg (caution)

PBR
5.26Industry Average 1.380.0Point

3.8x industry avg (risky)

ROE
26.28Industry Average 8.007.0Point

3.3x industry avg (excellent)

Debt Ratio
13.19Industry Average 11.652.0Point

Higher than industry avg (caution)

Trend 2023~20258.5 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲36.8% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲38.0% (2-year basis)

ROE Trend
2.5 / 4

Avg ROE 27.2% (declining, 3yr)

Detailed News Sentiment

11 totalPositive 8Neutral 3Negative 0Average Sentiment Score 73.2

Detailed Momentum

52-week position1.0Point

Near 52w low (5%, downtrend)

Current 44,500Won52-week high 75,60052-week low 42,650
1-month return0.0Point

1m -17.44% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

10 totalPositive 0Neutral 10Negative 0
  • Neutral[기재정정]타인에대한채무보증결정2026-06-09
  • Neutral기업설명회(IR)개최2026-06-04
  • Neutral기업설명회(IR)개최2026-05-28
  • Neutral지속가능경영보고서등관련사항(자율공시)2026-05-26
  • Neutral기업설명회(IR)개최2026-05-19